
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
Export 25 results:
Author Title [ Type
Filters: Author is Mansfield, K. E. [Clear All Filters]
“Acute kidney injury and infections in patients taking antihypertensive drugs: a self-controlled case series analysis”, Clin Epidemiol, vol. 10, pp. 187-202, 2018.
, “Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort study”, BMJ Open, vol. 7, p. e012818, 2017.
, “The association between partner bereavement and melanoma: cohort studies in the U.K. and Denmark”, Br J Dermatol, 2020.
, “Atopic eczema and fracture risk in adults: A population-based cohort study”, J Allergy Clin Immunol, 2019.
, “Atopic eczema and obesity: a population-based study”, Br J Dermatol, 2020.
, “Atopic eczema in adulthood and mortality: UK population-based cohort study, 1998-2016”, J Allergy Clin Immunol, 2021.
, “Atopic eczema in adulthood and risk of depression and anxiety: a population-based cohort study”, J Allergy Clin Immunol Pract, 2019.
, “Biochemical monitoring after initiation of aldosterone antagonist therapy in users of renin-angiotensin system blockers: a UK primary care cohort study”, BMJ Open, vol. 7, p. e018153, 2017.
, “Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study”, Wellcome Open Res, vol. 5, p. 77, 2020.
, “The effect of initiation of renin-angiotensin system inhibitors on haemoglobin: A national cohort study”, Br J Clin Pharmacol, 2020.
, “Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population-based cohort study”, Br J Clin Pharmacol, vol. 84, pp. 2142-2151, 2018.
, “Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study”, Lancet Digit Health, 2021.
, “Long-term effects of bariatric surgery on acute kidney injury: a propensity-matched cohort in the UK Clinical Practice Research Datalink”, BMJ Open, vol. 8, p. e020371, 2018.
, , “Mood Disorders and Risk of Herpes Zoster in 2 Population-Based Case-Control Studies in Denmark and the United Kingdom”, Am J Epidemiol, vol. 187, pp. 1019-1028, 2018.
, “Partner Bereavement and Risk of Herpes Zoster: Results from Two Population-Based Case-Control Studies in Denmark and the United Kingdom”, Clin Infect Dis, vol. 64, pp. 572-579, 2017.
, “Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study”, BMJ Open, vol. 6, p. e012690, 2016.
, “Prevalence, incidence, indication, and choice of antidepressants in patients with and without chronic kidney disease: a matched cohort study in UK Clinical Practice Research Datalink”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 792-801, 2017.
, “Proton pump inhibitors and risk of all-cause and cause-specific mortality: a cohort study”, Br J Clin Pharmacol, 2021.
, “Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data”, Bmj, vol. 368, p. l6987, 2020.
, “Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study”, Bmj, vol. 356, p. j791, 2017.
, “Severe mental illness and chronic kidney disease: a cross-sectional study in the United Kingdom”, Clin Epidemiol, vol. 10, pp. 421-429, 2018.
, “Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care”, BMC Med, vol. 18, p. 195, 2020.
, “Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study”, Bmj, vol. 360, p. k341, 2018.
, “Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom”, Nephrol Dial Transplant, vol. 32, pp. ii142-ii150, 2017.
,